English

• 
  
• 1. [1]

     Couvreur P., BlancoPrieto M. J., Puisieux F., Roques B., Fattal E.. Multiple emulsion technology for the design of microspheres containing peptides and oligopeptides[J]. Adv. Drug Deliv. Rev., 1997, 28(1):  85-96. doi: 10.1016/S0169-409X(97)00052-5

  2. [2]

     McGlohorn J. B., Grimes L. W., Webster S. S., Burg K. J. L.. Characterization of cellular carriers for use in injectable tissue-engineering composites[J]. J. Biomed. Mater. Res. Part A, 2003, 66A(3):  441-449. doi: 10.1002/(ISSN)1097-4636

  3. [3]

     Hong Y., Gao C. Y., Xie Y., Gong Y. H., Shen J. C.. Collagen-coated polylactide microspheres as chondrocyte microcarriers[J]. Biomaterials, 2005, 26(32):  6305-6313. doi: 10.1016/j.biomaterials.2005.03.038

  4. [4]

     Thissen H., Chang K. Y., Tebb T. A., Tsai W. B., Glattauer V., Ramshaw J. A. M., Werkmeister J. A.. Synthetic biodegradable microparticles for articular cartilage tissue engineering[J]. J. Biomed. Mater. Res. Part A, 2006, 77A(3):  590-598. doi: 10.1002/(ISSN)1552-4965

  5. [5]

     Liu X., Jin X., Ma P. X.. Nanofibrous hollow microspheres self-assembled from star-shaped polymers as injectable cell carriers for knee repair[J]. Nat. Mater., 2011, 10(5):  398-406. doi: 10.1038/nmat2999

  6. [6]

     Lee J. H., Lee C. S., Cho K. Y.. Enhanced cell adhesion to the dimpled surfaces of golf-ball-shaped microparticles[J]. ACS Appl. Mater. Interfaces, 2014, 6(19):  16493-16497. doi: 10.1021/am505997s

  7. [7]

     Kavas A., Keskin D., Altunbas K., Tezcaner A.. Raloxifene-/raloxifene-poly(ethylene glycol) conjugate-loaded microspheres:a novel strategy for drug delivery to bone forming cells[J]. Int. J. Pharm., 2016, 510(1):  168-183. doi: 10.1016/j.ijpharm.2016.06.053

  8. [8]

     Garkhal K., Verma S., Tikoo K., Kumar N.. Surface modified poly(L-lactide-co-epsilon-caprolactone) microspheres as scaffold for tissue engineering[J]. J. Biomed. Mater. Res. Part A, 2007, 82A(3):  747-756. doi: 10.1002/(ISSN)1552-4965

  9. [9]

     Lee S. H., Shin H.. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering[J]. Adv. Drug Deliv. Rev., 2007, 59(4-5):  339-359. doi: 10.1016/j.addr.2007.03.016

  10. [10]

      Luciani A., Coccoli V., Orsi S., Ambrosio L., Netti P. A.. PCL microspheres based functional scaffolds by bottom-up approach with predefined microstructural properties and release profiles[J]. Biomaterials, 2008, 29(36):  4800-4807. doi: 10.1016/j.biomaterials.2008.09.007

  11. [11]

      Bae S. E., Choi D. H., Han D. K., Park K.. Effect of temporally controlled release of dexamethasone on in vivo chondrogenic differentiation of mesenchymal stromal cells[J]. J. Control. Release, 2010, 143(1):  23-30. doi: 10.1016/j.jconrel.2009.12.024

  12. [12]

      Le Ray A. M., Chiffoleau S., Iooss P., Grimandi G., Gouyette A., Daculsi G., Merle C.. Vancomycin encapsulation in biodegradable poly(ε-caprolactone) microparticles for bone implantation.Influence of the formulation process on size, drug loading, in vitro release and cytocompatibility[J]. Biomaterials, 2003, 24(3):  443-449. doi: 10.1016/S0142-9612(02)00357-5

  13. [13]

      Bae S. E., Son J. S., Park K., Han D. K.. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine[J]. J. Control. Release, 2009, 133(1):  37-43. doi: 10.1016/j.jconrel.2008.09.006

  14. [14]

      Malda J., Frondoza C. G.. Microcarriers in the engineering of cartilage and bone[J]. Trends Biotechnol., 2006, 24(7):  299-304. doi: 10.1016/j.tibtech.2006.04.009

  15. [15]

      Crotts G., Park T. G.. Preparation of porous and nonporous biodegradable polymeric hollow microspheres[J]. J. Control. Release, 1995, 35(2-3):  91-105. doi: 10.1016/0168-3659(95)00010-6

  16. [16]

      Hong S. J., Yu H. S., Kim H. W.. Tissue engineering polymeric microcarriers with macroporous morphology and bone-bioactive surface[J]. Macromol. Biosci., 2009, 9(7):  639-645. doi: 10.1002/mabi.v9:7

  17. [17]

      Fan J. B., Song Y. Y., Wang S. T., Jiang L., Zhu M. Q., Guo X. L.. A synergy effect between the hydrophilic PEG and rapid solvent evaporation induced formation of tunable porous microspheres from a triblock copolymer[J]. RSC Adv., 2014, 4(2):  629-633. doi: 10.1039/C3RA44197K

  18. [18]

      Kim T. K., Yoon J. J., Lee D. S., Park T. G.. Gas foamed open porous biodegradable polymeric microspheres[J]. Biomaterials, 2006, 27(2):  152-159. doi: 10.1016/j.biomaterials.2005.05.081

  19. [19]

      Kang S. W., Yang H. S., Seo S. W., Han D. K., Kim B. S.. Apatite-coated poly(lactic-co-glycolic acid) microspheres as an injectable scaffold for bone tissue engineering[J]. J. Biomed. Mater. Res. Part A, 2008, 85A(3):  747-756. doi: 10.1002/(ISSN)1552-4965

  20. [20]

      Wu D., Wang C., Yang J., Wang H., Han H., Zhang A., Yang Y., Li Q.. Improving the intracellular drug concentration in lung cancer treatment through the codelivery of doxorubicin and mir-519c mediated by porous PLGA microparticle[J]. Mol. Pharm., 2016, 13(11):  3925-3933. doi: 10.1021/acs.molpharmaceut.6b00702

  21. [21]

      Iqbal M., Zafar N., Fessi H., Elaissari A.. Double emulsion solvent evaporation techniques used for drug encapsulation[J]. Int.J. Pharm., 2015, 496(2):  173-190. doi: 10.1016/j.ijpharm.2015.10.057

  22. [22]

      Shi X. D., Sun L., Jiang J., Zhang X. L., Ding W. J., Gan Z. H.. Biodegradable polymeric microcarriers with controllable porous structure for tissue engineering[J]. Macromol. Biosci., 2009, 9(12):  1211-1218. doi: 10.1002/mabi.v9:12

  23. [23]

      Shi X. D., Sun L., Gan Z. H.. Formation mechanism of solvent-induced porous PLA microspheres[J]. Acta Polymerica Sinica (in Chinese), 2011, (8):  866-873.

  24. [24]

      Wang S. Y., Shi X. D., Gan Z. H., Wang F.. Preparation of PLGA microspheres with different porous morphologies[J]. Chinese J. Polym. Sci., 2015, 33(1):  128-136. doi: 10.1007/s10118-014-1507-9

  25. [25]

      Odonnell P. B., McGinity J. W.. Preparation of microspheres by the solvent evaporation technique[J]. Adv. Drug Deliv. Rev., 1997, 28(1):  25-42. doi: 10.1016/S0169-409X(97)00049-5

  26. [26]

      Meng F. T., Ma G. H., Qiu W., Su Z. G.. W/O/W double emulsion technique using ethyl acetate as organic solvent:effects of its diffusion rate on the characteristics of microparticles[J]. J. Control. Release, 2003, 91(3):  407-416. doi: 10.1016/S0168-3659(03)00273-6

  27. [27]

      Zheng Y. H., Cheng Y. L., Chen J. J., Ding J. X., Li M. Q., Li C., Wang J.C., Chen X. S.. Injectable hydrogel-microsphere construct with sequential degradation for locally synergistic chemotherapy[J]. ACS Appl. Mater. Interfaces, 2017, 9(4):  3487-3496. doi: 10.1021/acsami.6b15245

  28. [28]

      Zhang J., Liu H., Ding J. X., Wu J., Zhuang X. L., Chen X. S., Wang J. C., Yin J. B., Li Z. M.. High-pressure compression-molded porous resorbable polymer/hydroxyapatite composite scaffold for cranial bone regeneration[J]. ACS Biomater. Sci. Eng., 2016, 2(9):  1471-1482. doi: 10.1021/acsbiomaterials.6b00202

  29. [29]

      Liu D. H., Ding J. X., Xu W. G., Song X. F., Zhuang X. L., Chen X. S.. Stereocomplex micelles based on 4-armed poly(ethylene glycol)-polylactide enantiomeric copolymers for drug delivery[J]. Acta Polymerica Sinica (in Chinese), 2014, (9):  1265-1273.

  30. [30]

      Shen K. X., Li D., Guan J. J., Ding J. X., Wang Z. T., Gu J. K., Liu T. J., Chen X. S.. Targeted sustained delivery of antineoplastic agent with multicomponent polylactide stereocomplex micelle[J]. Nanomed. Nanotechnol. Biol. Med., 2017, 13(3):  1279-1288. doi: 10.1016/j.nano.2016.12.022

  31. [31]

      Feng X. R., Ding J. X., Gref R., Chen X. S.. Poly(b-cyclodextrin)-mediated polylactide-cholesterol stereocomplex micelles for controlled drug delivery[J]. Chinese J. Polym. Sci., 2017, 35(6):  693-699. doi: 10.1007/s10118-017-1932-7

  32. [32]

      Wang J. X., Xu W. G., Ding J. X., Lu S. F., Wang X. Q., Wang C. X., Chen X. S.. Cholesterol-enhanced polylactide-based stereocomplex micelle for effective delivery of doxorubicin[J]. Materials, 2015, 8(1):  216-230. doi: 10.3390/ma8010216

  33. [33]

      Ho M. L., Fu Y. C., Wang G. J., Chen H. T., Chang J. K., Tsai T. H., Wang C. K.. Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite[J]. J. Control. Release, 2008, 128(2):  142-148. doi: 10.1016/j.jconrel.2008.02.012

  34. [34]

      Sturesson C., Carlfors J.. Incorporation of protein in PLG-microspheres with retention of bioactivity[J]. J. Control. Release, 2000, 67(2-3):  171-178. doi: 10.1016/S0168-3659(00)00205-4

  35. [35]

      Florence A. T., Whitehill D.. The formulation and stability of multiple emulsions[J]. Int. J. Pharm., 1982, 11:  277-308. doi: 10.1016/0378-5173(82)90080-1

  36. [36]

      Sah H. K., Smith M. S., Chern R. T.. A novel method of preparing PLGA microcapsules utilizing methylethyl ketone[J]. Pharm. Res., 1996, 13(3):  360-367. doi: 10.1023/A:1016080123176

  37. [37]

      Schugens C., Laruelle N., Nihant N., Grandfils C., Jerome R., Teyssie P.. Effect of the emulsion stability on the morphology and porosity of semicrystalline poly(L-lactide) microparticles prepared by W/O/W double emulsion-evaporation[J]. J. Control. Release, 1994, 32(2):  161-176. doi: 10.1016/0168-3659(94)90055-8

  38. [38]

      Rezwan K., Chen Q. Z., Blaker J. J., Boccaccini A. R.. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering[J]. Biomaterials, 2006, 27(18):  3413-3431. doi: 10.1016/j.biomaterials.2006.01.039

  39. [39]

      Bodmeier R., McGinity J.W.. Solvent selection in the preparation of poly(DL-lactide) microspheres prepared by the solvent evaporation method[J]. Int. J. Pharm., 1988, 43(1-2):  179-186. doi: 10.1016/0378-5173(88)90073-7

  40. [40]

      Kojima R., Yoshida T., Tasaki H., Umejima H., Maeda M., Higashi Y., Watanabe S., Oku N.. Release mechanisms of tacrolimus-loaded PLGA and PLA microspheres and immunosuppressive effects of the microspheres in a rat heart transplantation model[J]. Int. J. Pharm., 2015, 492(1-2):  20-27. doi: 10.1016/j.ijpharm.2015.07.004

  41. [41]

      Wei G. B., Pettway G. J., McCauley L. K., Ma P. X.. The release profiles and bioactivity of parathyroid hormone from poly(lactic-co-glycolic acid) microspheres[J]. Biomaterials, 2004, 25(2):  345-352. doi: 10.1016/S0142-9612(03)00528-3

  42. [42]

      Jones K. H., Senft J. A.. An improved method to determine cell viability by simultaneous staining with fluorescein diacetate propidium iodide[J]. J. Histochem. Cytochem., 1985, 33(1):  77-79. doi: 10.1177/33.1.2578146

  43. [43]

      Webb K., Hlady V., Tresco P. A.. Relative importance of surface wettability and charged functional groups on NIH 3T3 fibroblast attachment, spreading, and cytoskeletal organization[J]. J. Biomed. Mater. Res., 1998, 41(3):  422-430. doi: 10.1002/(ISSN)1097-4636

  44. [44]

      Kim H. K., Chung H. J., Park T. G.. Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone[J]. J. Control. Release, 2006, 112(2):  167-174. doi: 10.1016/j.jconrel.2006.02.004

  45. [45]

      Lee J., Lee K. Y.. Injectable microsphere/hydrogel combination systems for localized protein delivery[J]. Macromol. Biosci., 2009, 9(7):  671-676. doi: 10.1002/mabi.v9:7

  46. [46]

      Zhang Y., Sun L., Jiang J. A., Zhang X. L., Ding W. J., Gan Z. H.. Biodegradation-induced surface change of polymer microspheres and its influence on cell growth[J]. Polym. Degrad. Stab., 2010, 95(8):  1356-1364. doi: 10.1016/j.polymdegradstab.2010.01.025

•